首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1576930

耳鼻喉科用手持設備的全球市場:洞察，競爭情形，市場預測:2030年

ENT Handheld Instruments - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年10月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

在 2024 年至 2030 年的預測期內，全球耳鼻喉手持設備市場規模預計將以 6.36% 的複合年增長率擴大。耳鼻喉科（耳、鼻、喉）疾病負擔的增加，加上意識的提高和篩檢項目的增加，正在顯著推動耳鼻喉科手持設備市場的發展。此外，主要市場參與者的產品開發活動激增正在推動技術創新，並促使推出先進、易於使用和可自訂的耳鼻喉科手持設備，以滿足不同的消費者需求。這些因素結合起來創造了一個強勁的市場環境，推動了需求和供應，促使耳鼻喉手持設備產業在 2024 年至 2030 年的預測期內顯著成長。

根據世界衛生組織（WHO）最新數據（2024年），到2050年，近25億人將出現一定程度的聽力損失，至少7億人需要聽力復健。由於不安全的聆聽習慣，超過 10 億年輕人面臨本可避免的永久性聽力損失的風險。近 80% 的聽力損失者居住在低收入和中等收入國家。聽力損失的盛行率隨著年齡的增長而增加，60歲以上的人中有超過25%受到聽力損失的影響。

全球聽力損失人口的增加是推動耳鼻喉手持設備市場的關鍵因素。由於老化、環境因素和其他健康狀況導致聽力損失變得更加普遍，對有效的診斷和監測工具的需求不斷增長。手持式耳鼻喉設備（例如耳鏡和聽力計）在聽力損失的早期發現和治療中發揮著重要作用。對準確、便攜式和易於使用的設備來診斷和評估聽力損失的需求日益增長，正在推動先進手持技術開發的創新和投資。

本報告提供全球耳鼻喉科用手持設備市場相關調查，提供市場概要，以及各產品類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

Integra Lifesciences
Stryker
Medtronic plc.
SPIGGLE & THEIS Medizintechnik GmbH
Olympus Corporation
PRO-MED Instrumente GmbH
B. Braun Melsungen AG
Grace Medical
Heinz Kurz GmbH
Summit Medical LLC
Advin Healthcare
FENTEX medical GmbH.
Rica Surgical Products, Inc.
BLINK MEDICAL
Symmetry Surgical Inc.
Bailey Instruments Ltd.
Tonglu WANHE Medical Instrument Co.,Ltd.
Moonlight Surgical Works
SOLCO BIOMEDICAL CO., LTD.
ELMED Incorporated

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明和諮詢方式

簡介目錄圖表

Product Code: DIMDCL0160

ENT Handheld Instruments by Product Type (Otology Instruments, Rhinology Instruments, and Laryngeal Instruments), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising burden of ENT disorders, increasing awareness and screening programs, and technological advancements leading to increase in product development activities across the globe.

The global ENT handheld instruments market is expected to grow at a CAGR of 6.36% during the forecast period from 2024 to 2030. The rising burden of ENT (ear, nose, and throat) disorders, coupled with increasing awareness and screening programs, significantly drives the market for ENT handheld instruments. Additionally, the surge in product development activities by key market players fosters innovation, resulting in the introduction of advanced, user-friendly, and customizable ENT handheld instruments that meet diverse consumer needs. Together, these factors create a robust market environment, driving both demand and supply, and leading to significant growth in the ENT handheld instruments industry during the forecast period from 2024 to 2030.

ENT Handheld Instruments Market Dynamics:

According to the latest data provided by the World Health Organization (2024), by 2050, nearly 2.5 billion people were projected to have experienced some degree of hearing loss, with at least 700 million requiring hearing rehabilitation. Over 1 billion young adults were at risk of permanent, avoidable hearing loss due to unsafe listening practices. Nearly 80% of individuals with disabling hearing loss had lived in low- and middle-income countries. The prevalence of hearing loss had increased with age, with over 25% of those older than 60 years being affected by disabling hearing loss.

Furthermore, as per the recent data and stats provided by the Australian Government Department of Health and Aged Care (2024), approximately 3.6 million people had some level of hearing loss. As Australia's population aged, the number of individuals with hearing impairment was expected to double, reaching an estimated 7.8 million by 2060.

The increasing prevalence of hearing loss globally is a significant factor propelling the market for ENT handheld instruments. As hearing loss becomes more widespread due to aging populations, environmental factors, and other health conditions, the demand for effective diagnostic and monitoring tools rises. ENT handheld instruments, such as otoscopes and audiometers, play a crucial role in the early detection and management of hearing impairments. The growing need for accurate, portable, and user-friendly devices to diagnose and assess hearing loss drives innovation and investment in the development of advanced handheld technologies.

According to the latest data provided by GLOBOCAN (2024), in 2022 globally the new cases of larynx cancer was 189,000 and was estimated to rise to 228,000 by 2030. As per the same source in 2022 there were approximately 40,000 new cases of larynx cancer in Europe. Furthermore, as per the same source, in 2022 globally the new cases of oropharynx and nasopharynx cancer was 22700 and is expected to rise to 265000.

Larynx cancer, oropharynx cancer, and nasopharynx cancer are all significant contributors to the rising demand for ENT handheld instruments, as these cancers directly affect critical areas of the head and neck region. The need for precise diagnostic and therapeutic procedures in treating these cancers has heightened the demand for advanced handheld instruments such as laryngoscopes, nasopharyngoscopes, and oropharyngoscopes. These cancers often require intricate surgical interventions and frequent biopsies, necessitating the use of specialized instruments designed for access to hard-to-reach areas within the throat, ear, and throat thereby escalating the demand for ENT handheld instruments across the region.

However, the risk of injury, discomfort, infection, limited visualization, and stringent regulatory concerns for product approval may hinder the future market of ENT handheld instruments.

ENT Handheld Instruments Market Segment Analysis:

In the product type segment of ENT handheld instruments market the rhinology instruments are expected to hold a significant share in 2023. Rhinology instruments are playing a significant role in driving the overall growth of the ENT handheld instruments market, largely due to the increasing prevalence of nasal and sinus conditions and the growing demand for minimally invasive procedures. The rise in chronic rhino sinusitis, allergic rhinitis, and other nasal disorders has led to a surge in demand for specialized rhinology instruments, such as nasal speculums, septal elevators, nasal forceps, and sinus seekers. According to the recent data and stats provided by Centre for Disease Control and Prevention (2022), approximately, 28.9 million of adults were diagnosed with sinusitis in the United States.

Additionally, these tools are essential for performing a variety of diagnostic and therapeutic procedures, including endoscopic sinus surgery, septoplasty, and turbinate reduction. The trend towards minimally invasive surgeries is particularly noteworthy, as patients increasingly seek treatments that offer faster recovery times and less postoperative discomfort. This shift has prompted manufacturers to innovate and develop advanced rhinology instruments that are more precise, ergonomic, and adaptable to various surgical techniques. Furthermore, their precision and ability to provide detailed visualization of the nasal cavity and sinuses, which enhances diagnostic accuracy. Modern rhinology instruments, such as flexible endoscopes with high-definition cameras, allow for real-time imaging, enabling physicians to conduct thorough examinations and make more informed decisions. This improved diagnostic capability leads to better patient outcomes and more targeted treatments.

Additionally, an increase in product development activities are also anticipated to augment the rhinology instrument market growth For instance, in September 2023 Olympus Corporation launched Vathin E-SteriScope(TM) single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures.

Therefore, owing to the above-mentioned factors, the rhinology instrument category is expected to generate considerable revenue thereby pushing the overall growth of the global ENT handheld instruments market during the forecast period.

North America is expected to dominate the overall ENT Handheld Instruments market:

North America is expected to account for the highest proportion of the ENT handheld instruments market in 2023, out of all regions. This can be ascribed to the increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, laryngeal and pharyngeal cancer, increase government initiatives coupled with increased awareness programs for ENT disorders, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of ENT handheld instruments during the forecast period.

According to the most recent estimates provided by the American Cancer Society, in 2024 there were approximately 12,650 new cases of laryngeal cancer in which 10,030 were men and 2,620 were women in the United States. Additionally, as per the data provided by the GLOBOCAN (2024) in 2022 there were approximately 13,000 new cases of laryngeal cancer and about 18,000 new cases of oropharynx and nasopharynx cancer in North America. Laryngeal cancer, which affects the voice box, and oropharyngeal and nasopharyngeal cancers, which involve the throat and nasal passages, often require detailed visualization and biopsy procedures to diagnose and monitor progression. Handheld instruments such as flexible endoscopes, laryngoscopes, and fiber-optic scopes are crucial for providing high-resolution images of the affected areas, enabling clinicians to detect tumors at an early stage, plan surgical interventions, and guide radiation therapy thereby boosting the overall market of ENT handheld instruments across the region.

Furthermore, as per the recent data provided by National Council of Aging (2023), hearing loss affected about 60.7 million Americans aged 12 and older accounting approximately 15.5% (44.1 million) of American adults aged 20 and older had some level of hearing loss. Handheld devices such as otoscopes, audiometers, and tympanometers are critical in evaluating the health of the ear canal, middle ear, and hearing functions. These instruments enable healthcare providers to conduct thorough examinations, identify the underlying causes of hearing loss, and tailor appropriate treatment plans thereby boosting the overall market of ENT handheld instruments across the region.

Therefore, the above-mentioned factors are expected to bolster the growth of the ENT handheld instruments market in North America during the forecast period.

ENT Handheld Instruments Market Key Players:

Some of the key market players operating in the ENT handheld instruments market include Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated, and others.

Recent Developmental Activities in the ENT Handheld Instruments Market:

In May 2024, Olympus, announced the release of the DVM-B2 Digital Video Monitor. This all-in-one video processor and monitor was designed for use with single-use endoscopes in bronchoscopy and ENT, including the H-SteriScope(TM) Single-use Flexible Bronchoscopes and the E-SteriScope(TM) Single-use Flexible Rhinolaryngoscopes.
In September 2023 Penlon, a global producer of medical devices in UK launched new Diamond Video Laryngoscopes, a portable device which gives increased field of view as compared to other direct rigid laryngoscopes.

Key Takeaways From the ENT Handheld Instruments Market Report Study:

Market size analysis for current ENT handheld instruments size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the ENT handheld instruments market.
Various opportunities available for the other competitors in the ENT handheld instruments market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current ENT handheld instruments market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ENT handheld instruments market growth in the coming future?

Target Audience who can be Benefited From This ENT Handheld Instruments Market Report Study:

ENT handheld instruments product providers
Research organizations and consulting companies
ENT handheld instruments -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in ENT handheld instruments
Various end-users who want to know more about the ENT handheld instruments market and the latest technological developments in the ENT handheld instruments market.

Frequently Asked Questions for the ENT Handheld Instruments Market:

1. What are ENT handheld instruments?

An ENT handheld instrument is a device which are majorly employed during various ENT surgeries and specialized according to the structure being operated on such as otology-handheld instruments, rhinology instruments, and others.

2. What is the market for ENT handheld instruments?

The global ENT handheld instruments market is expected to grow at a CAGR of 6.36% during the forecast period from 2024 to 2030.

3. What are the drivers for the ENT handheld instruments market?

The rising burden of ENT (ear, nose, and throat) disorders, coupled with increasing awareness and screening programs, significantly drives the market for ENT handheld instruments. Additionally, the surge in product development activities by key market players fosters innovation, resulting in the introduction of advanced, user-friendly, and customizable ENT handheld instruments that meet diverse consumer needs. Together, these factors create a robust market environment, driving both demand and supply, and leading to significant growth in the ENT handheld instruments industry during the forecast period from 2024 to 2030.

4. Who are the key players operating in the ENT Handheld Instruments market?

Some of the key market players operating in the ENT handheld instruments market include Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated, and others.

5. Which region has the highest share in the ENT Handheld Instruments market?

North America is expected to account for the highest proportion of the ENT handheld instruments market in 2023, out of all regions. This can be ascribed to the increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, laryngeal and pharyngeal cancer, increase government initiatives coupled with increased awareness programs for ENT disorders, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of ENT handheld instruments during the forecast period.

1. ENT Handheld Instruments Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. ENT Handheld Instruments Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. ENT Handheld Instruments Market Key Factors Analysis

5.1. ENT Handheld Instruments Market Drivers
- 5.1.1. Rising burden of ENT disorders
- 5.1.2. Increasing awareness and screening programs
- 5.1.3. Technological advancements leading to increase in product development activities
5.2. ENT Handheld Instruments Market Restraints and Challenges
- 5.2.1. Risk of injury, discomfort, infection, and limited visualization
- 5.2.2. Stringent regulatory concerns for product approval
5.3. ENT Handheld Instruments Market Opportunities
- 5.3.1. Integration with digital devices telemedicine and remote patient monitoring

6. ENT Handheld Instruments Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. ENT Handheld Instruments Market Assessment

7.1. By Product Type
- 7.1.1. Otology Handheld Instruments
- 7.1.2. Rhinology Handheld Instruments
- 7.1.3. Laryngeal Handheld Instruments
7.2. By End User
- 7.2.1. Hospitals
- 7.2.2. Specialty Clinics
- 7.2.3. Ambulatory Surgical Centers
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.1.2. Canada ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.1.3. Mexico ENT Handheld Instruments Market Size in USD Million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.2.2. Germany ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.2.3. United Kingdom ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.2.4. Italy ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.2.5. Spain ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.2.6. Rest of Europe ENT Handheld Instruments Market Size in USD Million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.3.2. Japan ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.3.3. India ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.3.4. Australia ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.3.5. South Korea ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific ENT Handheld Instruments Market Size in USD Million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.4.2. Africa ENT Handheld Instruments Market Size in USD Million (2021-2030)
  - 7.3.4.3. South America ENT Handheld Instruments Market Size in USD Million (2021-2030)

8. ENT Handheld Instruments Market Company and Product Profiles

8.1. Integra Lifesciences
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Stryker
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Medtronic plc.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. SPIGGLE & THEIS Medizintechnik GmbH
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Olympus Corporation
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. PRO-MED Instrumente GmbH
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. B. Braun Melsungen AG
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Grace Medical
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Heinz Kurz GmbH
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Summit Medical LLC
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Advin Healthcare
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. FENTEX medical GmbH.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Rica Surgical Products, Inc.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. BLINK MEDICAL
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Symmetry Surgical Inc.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Bailey Instruments Ltd.
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Tonglu WANHE Medical Instrument Co.,Ltd.
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Moonlight Surgical Works
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. SOLCO BIOMEDICAL CO., LTD.
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. ELMED Incorporated
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy